Literature DB >> 16554918

Pathology of chronic obstructive pulmonary disease.

Mária Szilasi1, Tamás Dolinay, Zoltán Nemes, János Strausz.   

Abstract

Chronic obstructive pulmonary disease is one of the leading causes of death and morbidity worldwide. Despite intensive investigation, its pathology and pathophysiology are not well understood. The hallmarks of the disease are irreversible airflow limitation and chronic inflammation. Small airway obstruction due to progressive inflammation and fibrosis, and the loss of elastic recoil mediated by elastolysis and apoptosis equally contribute to pathologic changes. However, it is debated to what extent the obstruction of large airways leads to altered lung function. Three morphologic entities are described in the literature under one disease; chronic bronchitis, obstructive bronchiolitis and emphysema may appear in the same patient at the same time. The authors review pathologic changes observed in chronic obstructive pulmonary disease, including acute exacerbations and secondary pulmonary hypertension as severe but common complications of the disease. Furthermore, we detail recent scientific evidences for major cellular and molecular inflammatory pathway activation. These mechanisms result in accelerated apoptosis, remodeling and increased proinflammatory cytokine release. Targeting intracellular pathological changes may lead to the discovery of a new generation of drugs that could reduce chronic obstruction before airway irreversibility is established.

Entities:  

Mesh:

Year:  2006        PMID: 16554918     DOI: 10.1007/bf02893433

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  61 in total

1.  Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation.

Authors:  M Saetta; G Turato; S Baraldo; A Zanin; F Braccioni; C E Mapp; P Maestrelli; G Cavallesco; A Papi; L M Fabbri
Journal:  Am J Respir Crit Care Med       Date:  2000-03       Impact factor: 21.405

2.  Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.

Authors:  A N Liu; A Z Mohammed; W R Rice; D T Fiedeldey; J S Liebermann; J A Whitsett; T J Braciale; R I Enelow
Journal:  Am J Respir Cell Mol Biol       Date:  1999-05       Impact factor: 6.914

Review 3.  Airway inflammation in chronic obstructive pulmonary disease.

Authors:  M Saetta
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

4.  Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.

Authors:  A R Kranenburg; W I de Boer; V K T Alagappan; P J Sterk; H S Sharma
Journal:  Thorax       Date:  2005-02       Impact factor: 9.139

5.  Epidermal growth factor system regulates mucin production in airways.

Authors:  K Takeyama; K Dabbagh; H M Lee; C Agustí; J A Lausier; I F Ueki; K M Grattan; J A Nadel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

6.  Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease.

Authors:  B E Lams; A R Sousa; P J Rees; T H Lee
Journal:  Eur Respir J       Date:  2000-03       Impact factor: 16.671

7.  Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease.

Authors:  Salud Santos; Victor I Peinado; Josep Ramirez; Jaime Morales-Blanhir; Ricardo Bastos; Josep Roca; Robert Rodriguez-Roisin; Joan A Barbera
Journal:  Am J Respir Crit Care Med       Date:  2003-02-20       Impact factor: 21.405

8.  Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease.

Authors:  Yusheng Qiu; Jie Zhu; Venkata Bandi; Robert L Atmar; Keith Hattotuwa; Kay K Guntupalli; Peter K Jeffery
Journal:  Am J Respir Crit Care Med       Date:  2003-07-11       Impact factor: 21.405

9.  Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease.

Authors:  Wen Ning; Chao-Jun Li; Naftali Kaminski; Carol A Feghali-Bostwick; Sean M Alber; Yuanpu P Di; Sherrie L Otterbein; Ruiping Song; Shizu Hayashi; Zhihong Zhou; David J Pinsky; Simon C Watkins; Joseph M Pilewski; Frank C Sciurba; David G Peters; James C Hogg; Augustine M K Choi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-05       Impact factor: 11.205

Review 10.  Systemic inflammation in chronic obstructive pulmonary disease.

Authors:  E J D Oudijk; J W J Lammers; L Koenderman
Journal:  Eur Respir J Suppl       Date:  2003-11
View more
  11 in total

Review 1.  Autophagy: a core cellular process with emerging links to pulmonary disease.

Authors:  Jeffrey A Haspel; Augustine M K Choi
Journal:  Am J Respir Crit Care Med       Date:  2011-08-11       Impact factor: 21.405

Review 2.  Morphological and functional imaging in COPD with CT and MRI: present and future.

Authors:  Julia Ley-Zaporozhan; Sebastian Ley; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2007-09-27       Impact factor: 5.315

Review 3.  Airway epithelial stem cells and the pathophysiology of chronic obstructive pulmonary disease.

Authors:  Scott H Randell
Journal:  Proc Am Thorac Soc       Date:  2006-11

4.  Computed tomography manifestation of acute exacerbation of chronic obstructive pulmonary disease: A pilot study.

Authors:  Ting Cheng; Huanying Wan; Qijian Cheng; Y I Guo; Yanrong Qian; Liang Fan; Yun Feng; Yanyan Song; Min Zhou; Qingyun Li; Guochao Shi; Shaoguang Huang
Journal:  Exp Ther Med       Date:  2015-12-11       Impact factor: 2.447

5.  Cyclic AMP-responsive element binding protein- and nuclear factor-kappaB-regulated CXC chemokine gene expression in lung carcinogenesis.

Authors:  Hongxia Sun; Wen-Cheng Chung; Seung-Hee Ryu; Zhenlin Ju; Hai T Tran; Edward Kim; Jonathan M Kurie; Ja Seok Koo
Journal:  Cancer Prev Res (Phila)       Date:  2008-10

6.  Differential cytokine pattern in the exhaled breath of patients with lung cancer.

Authors:  Tamás Kullmann; Imre Barta; Eszter Csiszér; Balázs Antus; Ildikó Horváth
Journal:  Pathol Oncol Res       Date:  2008-04-16       Impact factor: 3.201

7.  Inflammatory mechanisms in the lung.

Authors:  B Moldoveanu; P Otmishi; P Jani; J Walker; X Sarmiento; J Guardiola; M Saad; Jerry Yu
Journal:  J Inflamm Res       Date:  2008-12-16

Review 8.  Role of TNFalpha in pulmonary pathophysiology.

Authors:  Srirupa Mukhopadhyay; John R Hoidal; Tapan K Mukherjee
Journal:  Respir Res       Date:  2006-10-11

9.  Cigarette smoking and tuberculosis in Cambodia: findings from a national sample.

Authors:  Pramil N Singh; Daravuth Yel; They Kheam; Glorietta Hurd; Jayakaran S Job
Journal:  Tob Induc Dis       Date:  2013-03-27       Impact factor: 2.600

10.  Sodium Tanshinone IIA Sulfonate Decreases Cigarette Smoke-Induced Inflammation and Oxidative Stress via Blocking the Activation of MAPK/HIF-1α Signaling Pathway.

Authors:  Ruijuan Guan; Jian Wang; Ziying Li; Mingjing Ding; Defu Li; Guihua Xu; Tao Wang; Yuqin Chen; Qian Yang; Zhen Long; Zhou Cai; Chenting Zhang; Xue Liang; Lian Dong; Li Zhao; Haiyun Zhang; Dejun Sun; Wenju Lu
Journal:  Front Pharmacol       Date:  2018-05-01       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.